Table 5.
Cost-effectiveness analysis for percentage of responders on CGI, immediate and 6 months
| Condition | Mean total cost per patient ($, 2016) (SE) | Immediate intent-to-treat (ITT) outcomes | 6-Month intent-to-treat (ITT) outcomes | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Percentage of responders (based on patient-reported CGI) | Percentage of responders (based on physician-reported CGI) | Percentage of responders (based on patient-reported CGI) | Percentage of responders (based on physician-reported CGI) | ||||||
| Mean effectivenessa (SE) | ICER (ΔC/ΔE, $) | Mean effectivenessa (SE) | ICER (ΔC/ΔE, $) | Mean effectivenessa (SE) | ICER (ΔC/ΔE, $) | Mean effectivenessa (SE) | ICER (ΔC/ΔE, $) | ||
| MC-CBT | 348a,b | 61.0%a,b | – | 55.7%a,b | – | 56.6%a.b | – | 58.4%a,b | – |
| (9.32) | (0.01) | (0.004) | (0.01) | (0.004) | |||||
| EDU | 457b,c | 43.5%b,c | Economically dominated | 40.4%b,c | Economically dominated | 47.0%b | Economically dominated | 44.8%b,c | Economically dominated |
| (10.37) | (0.005) | (0.004) | (0.01) | (0.005) | |||||
| S-CBT | 644a,c (19.20) | 54.5%a,c (0.01) | Economically dominated | 50.6%a,c (0.004) | Economically dominated | 48.1%a (0.01) | Economically dominated | 51.6%a,c (0.005) | Economically dominated |
Note. Standard errors of the averages are presented in parentheses.
aStatistically significant difference between MC-CBT and S-CBT averages at the .001 level.
bStatistically significant difference between MC-CBT and EDU averages at the .001 level.
cStatistically significant difference between S-CBT and EDU averages at the .001 level.